GENZYME CORP
S-4/A, EX-23.7, 2000-10-27
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: GENZYME CORP, S-4/A, EX-23.4, 2000-10-27
Next: GENZYME CORP, S-4/A, EX-23.8, 2000-10-27



<PAGE>

Exhibit 23.7


                           CONSENT OF LEHMAN BROTHERS


     We hereby consent to the use of our opinion letter dated March 6, 2000 to
the Board of Directors of Biomatrix (the "Company") attached as Appendix C to
the Company's Joint Proxy Statement/Prospectus on Form S-4 (the "Prospectus")
and to the references to our firm in the Prospectus under the headings
"Background and Reasons for the Merger" and "Fairness Opinion of Biomatrix'
Financial Advisor." In giving such consent, we do not admit that we come within
the category of persons whose consent is required under Section 7 of the
Securities Act of 1933, as amended, or the rules and regulations of the
Securities and Exchange Commission thereunder and we do not thereby admit that
we are experts with respect to any part of the Registration Statement under the
meaning of the term "expert" as used in the Securities Act.

                                        LEHMAN BROTHERS INC.



                                    By: /s/ Kevin R. Genirs
                                       -----------------------------------
                                       Title: Kevin R. Genirs
                                       Senior Vice President

New York, New York
October 26, 2000





© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission